Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

L.A. McKeown

August 23, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

News Daily News

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Michael O'Riordan

November 14, 2019

News Daily News

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Caitlin E. Cox

May 14, 2019

News Daily News

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

L.A. McKeown

May 06, 2019

News Daily News

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

Michael O'Riordan

May 06, 2019

News Daily News

FDA Approves Lotus Edge, Ushering Third Device Into US Market

Shelley Wood

April 24, 2019

News Daily News

FDA Extends MitraClip Indication to Include Functional MR

Shelley Wood

March 14, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for January 2019

Caitlin E. Cox

January 31, 2019

News Daily News

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Michael O'Riordan

November 01, 2018

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

News Daily News

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

Caitlin E. Cox

September 05, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Michael O'Riordan

July 20, 2018

News Daily News

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Michael O'Riordan

May 08, 2018

News Conference News ACC 2018

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Michael O'Riordan

March 11, 2018

Advertisement

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl

Details in Print for DanGer Design as Impella AMICS RCT Expands From Denmark to Germany

Vici Venous Stent Receives FDA Approval for Iliofemoral Obstructive Disease

Tafamidis Approved for Treatment of Transthyretin Amyloid Cardiomyopathy

FDA Approves Lotus Edge, Ushering Third Device Into US Market

FDA Extends MitraClip Indication to Include Functional MR

TCTMD’s Top 10 Most Popular Stories for January 2019

FDA Puts the Kibosh on Canakinumab for Cardiac Indication—at Least for Now

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

CV Devices in the Fast Lane: FDA’s Approval Often Rests on Early Evidence

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

High-Risk Medical Device Approval Process in Europe Inches Towards Transparency

Implantable Cardiac Monitor for High-Risk ACS Patients Wins FDA Approval

Bad BVS News: Analysis Points to Fast Reaction by Interventionalists to Absorb Safety Issues

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content